These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

888 related items for PubMed ID: 15933529

  • 21. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles.
    Gobbo S, Eble JN, Delahunt B, Grignon DJ, Samaratunga H, Martignoni G, Zhang S, Wang M, Brunelli M, Cossu-Rocca P, Cheng L.
    Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical profile of common epithelial neoplasms arising in the kidney.
    Kim MK, Kim S.
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):332-8. PubMed ID: 12613443
    [Abstract] [Full Text] [Related]

  • 23. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
    Geramizadeh B, Ravanshad M, Rahsaz M.
    Indian J Pathol Microbiol; 2008 Dec; 51(2):167-71. PubMed ID: 18603673
    [Abstract] [Full Text] [Related]

  • 24. The diagnostic value of cytokeratins expression in the renal parenchyma tumors.
    Alexa A, Baderca F, Lighezan R, Izvernariu D, Raica M.
    Rom J Morphol Embryol; 2010 Dec; 51(1):27-35. PubMed ID: 20191116
    [Abstract] [Full Text] [Related]

  • 25. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
    Taki A, Nakatani Y, Misugi K, Yao M, Nagashima Y.
    Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
    [Abstract] [Full Text] [Related]

  • 26. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
    Meer S, Altini M.
    Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
    [Abstract] [Full Text] [Related]

  • 27. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
    Weinbreck N, Marie B, Bressenot A, Montagne K, Joud A, Baumann C, Klein O, Vignaud JM.
    Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
    [Abstract] [Full Text] [Related]

  • 28. Collision renal tumors.
    Vasuri F, Fellegara G.
    Int J Surg Pathol; 2009 Aug; 17(4):338-9. PubMed ID: 18611936
    [No Abstract] [Full Text] [Related]

  • 29. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY, Kim HS, Hong EK, Kim WH.
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [Abstract] [Full Text] [Related]

  • 30. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
    Gyure KA, Morrison AL.
    Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
    [Abstract] [Full Text] [Related]

  • 31. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP, Papavero V, Sugimura J, Teh BT, Yang XJ.
    Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
    [Abstract] [Full Text] [Related]

  • 32. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
    Lewis JE, Olsen KD, Sebo TJ.
    Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
    [Abstract] [Full Text] [Related]

  • 33. Hybrid chromophobe renal cell neoplasm.
    Mai KT, Dhamanaskar P, Belanger E, Stinson WA.
    Pathol Res Pract; 2005 Jun; 201(5):385-9. PubMed ID: 16047948
    [Abstract] [Full Text] [Related]

  • 34. [Papillary renal cell carcinoma: clinico-pathologic studies of 33 cases].
    Liu LN, Chen GY, Wang P, Zhang CH, Huang SF.
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):102-5. PubMed ID: 15946550
    [Abstract] [Full Text] [Related]

  • 35. Expression of vitamin D3 receptor in kidney tumors.
    Liu W, Tretiakova M, Kong J, Turkyilmaz M, Li YC, Krausz T.
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC, Chen PC, Chiang H.
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [Abstract] [Full Text] [Related]

  • 37. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma.
    Orsola A, Trias I, Raventós CX, Español I, Cecchini L, Orsola I.
    Urology; 2005 Jan; 65(1):49-54. PubMed ID: 15667862
    [Abstract] [Full Text] [Related]

  • 38. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases.
    Hes O, Brunelli M, Michal M, Cossu Rocca P, Hora M, Chilosi M, Mina M, Boudova L, Menestrina F, Martignoni G.
    Ann Diagn Pathol; 2006 Jun; 10(3):133-9. PubMed ID: 16730306
    [Abstract] [Full Text] [Related]

  • 39. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics.
    Carvalho JC, Wasco MJ, Kunju LP, Thomas DG, Shah RB.
    Histopathology; 2011 Jan; 58(2):169-79. PubMed ID: 21323945
    [Abstract] [Full Text] [Related]

  • 40. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC, Barocas DA, Chen YT, Yang XJ, Scherr DS, Tu JJ.
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.